CU Medical Systems

At a glance

CU Medical Systems filed 39 disclosures in the last 12 months, including 7 5% holder, 3 insider, 1 issuance and 1 m&a. The most recent key filing was on Aug 10.

Revenue for 2025 was ₩48.2B, up 18.7% on 2024. Operating margin was 22.4% against 19.2% a year earlier. Debt was 67% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩35.4B and operating profit of ₩8.5B.

The 2025 annual report lists 113 employees with an average tenure of 6.1 years and average pay of ₩52.9M, #1317 of 1,829 listed companies by average pay. Its 7 directors and auditors were paid ₩196M each on average. It paid no cash dividend for 2025. (주)씨유코퍼레이션(*) and related parties held 35.52% at year end.

From the 2025 annual report

Staff: 113 (56 men, 57 women), of whom 0 on fixed-term contracts. Total pay for the year: ₩6B. Directors and auditors: 7, paid ₩1.4B in total.

No cash dividend was paid for 2025.

Largest shareholder

(주)씨유코퍼레이션(*) holds 22.82%; with 2 related parties the group holds 35.52% of common shares at year end.

Individuals paid ₩500M or more

Auditor: 삼덕회계법인 · opinion: Unqualified. The report includes an emphasis of matter.

Source: 2025 annual business report (DART). How figures are combined

Financial summary